Tilray | TRLY - Ricavi Di Vendita

Prezzo Delle Azioni
8.38
Cambio Giornaliero
-0.58 -6.47%
Mensile
0.36%
Annuale
1,132.35%
Q2 Previsione
9.04




I Saldi Cambiamento Data
Acasti Pharma USD -4.76M 4.76M 2024-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Cronos Group USD 58.39M 22.05M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Ionis Pharmaceuticals USD 246M 43M 2026-03
IQVIA Holdings USD 4.36B 260M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Moderna USD 678M 342M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Organon & Co USD 1.51B 90M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.7B 60M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12